AllianceBernstein saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 69 to 73.
IBD's unique rating measures market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the market's biggest winners typically have an RS Rating north of 80 as they launch their biggest climbs. See if AllianceBernstein can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
While AllianceBernstein is not near a proper buying range right now, see if it manages to form and break out of a proper chart pattern.
AllianceBernstein saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 16% to 18%. Revenue rose from 2% to 4%.
The company earns the No. 31 rank among its peers in the Finance-Investment Management industry group. KKR, Blue Owl Capital and P10 are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
